Peng Hui, Lan Chaowang, Zheng Yi, Hutvagner Gyorgy, Tao Dacheng, Li Jinyan
Advanced Analytics Institute, University of Technology Sydney, PO Box 123, Broadway, 2007, NSW, Australia.
Centre for Health Technologies, University of Technology Sydney, PO Box 123, Broadway, 2007, NSW, Australia.
BMC Bioinformatics. 2017 Mar 24;18(1):193. doi: 10.1186/s12859-017-1605-0.
MicroRNAs always function cooperatively in their regulation of gene expression. Dysfunctions of these co-functional microRNAs can play significant roles in disease development. We are interested in those multi-disease associated co-functional microRNAs that regulate their common dysfunctional target genes cooperatively in the development of multiple diseases. The research is potentially useful for human disease studies at the transcriptional level and for the study of multi-purpose microRNA therapeutics.
We designed a computational method to detect multi-disease associated co-functional microRNA pairs and conducted cross disease analysis on a reconstructed disease-gene-microRNA (DGR) tripartite network. The construction of the DGR tripartite network is by the integration of newly predicted disease-microRNA associations with those relationships of diseases, microRNAs and genes maintained by existing databases. The prediction method uses a set of reliable negative samples of disease-microRNA association and a pre-computed kernel matrix instead of kernel functions. From this reconstructed DGR tripartite network, multi-disease associated co-functional microRNA pairs are detected together with their common dysfunctional target genes and ranked by a novel scoring method. We also conducted proof-of-concept case studies on cancer-related co-functional microRNA pairs as well as on non-cancer disease-related microRNA pairs.
With the prioritization of the co-functional microRNAs that relate to a series of diseases, we found that the co-function phenomenon is not unusual. We also confirmed that the regulation of the microRNAs for the development of cancers is more complex and have more unique properties than those of non-cancer diseases.
微小RNA在基因表达调控中总是协同发挥作用。这些协同功能的微小RNA功能失调在疾病发展中可能起重要作用。我们关注那些在多种疾病发展过程中协同调控其共同功能失调靶基因的多疾病相关协同功能微小RNA。该研究在转录水平上对人类疾病研究以及多用途微小RNA治疗研究可能具有重要意义。
我们设计了一种计算方法来检测多疾病相关协同功能微小RNA对,并在重建的疾病-基因-微小RNA(DGR)三方网络上进行跨疾病分析。DGR三方网络的构建是通过将新预测的疾病-微小RNA关联与现有数据库中保存的疾病、微小RNA和基因之间的关系整合而成。该预测方法使用一组可靠的疾病-微小RNA关联阴性样本和预先计算的核矩阵,而不是核函数。从这个重建的DGR三方网络中,检测出多疾病相关协同功能微小RNA对及其共同功能失调靶基因,并通过一种新的评分方法进行排名。我们还对癌症相关协同功能微小RNA对以及非癌症疾病相关微小RNA对进行了概念验证案例研究。
通过对与一系列疾病相关的协同功能微小RNA进行优先级排序,我们发现协同功能现象并不罕见。我们还证实,微小RNA对癌症发展的调控比非癌症疾病更为复杂,且具有更多独特特性。